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Abstract
Mechanisms by which viruses counter innate host defense responses generally involve inhibition of one or more
components of the interferon (IFN) system. Multiple steps in the induction and amplification of IFN signaling are targeted
for inhibition by viral proteins, and many of the IFN antagonists have direct or indirect effects on activation of latent
cytoplasmic transcription factors. Rotavirus nonstructural protein NSP1 blocks transcription of type I IFNa/b by inducing
proteasome-dependent degradation of IFN-regulatory factors 3 (IRF3), IRF5, and IRF7. In this study, we show that rotavirus
NSP1 also inhibits activation of NFkB and does so by a novel mechanism. Proteasome-mediated degradation of inhibitor of
kB( I kBa) is required for NFkB activation. Phosphorylated IkBa is a substrate for polyubiquitination by a multisubunit E3
ubiquitin ligase complex, Skp1/Cul1/F-box, in which the F-box substrate recognition protein is b-transducin repeat
containing protein (b-TrCP). The data presented show that phosphorylated IkBa is stable in rotavirus-infected cells because
infection induces proteasome-dependent degradation of b-TrCP. NSP1 expressed in isolation in transiently transfected cells
is sufficient to induce this effect. Targeted degradation of an F-box protein of an E3 ligase complex with a prominent role in
modulation of innate immune signaling and cell proliferation pathways is a unique mechanism of IFN antagonism and
defines a second strategy of immune evasion used by rotaviruses.
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Introduction
Research into mechanisms by which viruses evade host defense
has received increased attention in the past several years because
of the potential to develop attenuated vaccines based on viruses
with weakened evasion strategies, or antiviral therapies that target
specific immune system antagonists. Most, if not all, viruses encode
proteins that interfere with signal transduction pathways involved
in induction or amplification of the immune response, particularly
the innate response driven by type I interferon (IFNa/b) [1].
IFNa/b are cytokines that stimulate expression of genes that
interfere directly with steps in the virus replication cycle, and genes
whose protein products modulate and recruit the adaptive
immune response. The antiviral state that is established by the
IFN system serves to restrict virus replication and spread while
effectors of the slower adaptive immune response are recruited to
the site of infection.
The mechanisms of IFNa/b induction are relatively well
understood [2] although proteins involved in this pathway
continue to be identified [3,4,5]. Induction of IFNb transcription
occurs through assembly of transcription factors interferon
regulatory factor 3 (IRF3), NFkB, and ATF2/c-Jun on the
positive regulatory domain enhancer element of the IFNb
promoter, and the interferon stimulated response element (ISRE)
in promoters of a subset IFN-stimulated genes (ISG) [6,7,8].
Secreted IFNb binds to cell surface type I IFN receptors and
activates the JAK/STAT pathway, resulting in formation of IFN-
stimulated gene factor-3 (ISGF3). ISGF3 is a heterotrimeric
complex consisting of STAT1, STAT2, and IRF9. ISGF3
translocates to the nucleus and induces transcription of IFNa
and numerous ISGs, thus amplifying the response through a
positive feedback mechanism. Each of the steps in the IFN
signaling pathway has been reported as targets for viral IFN
antagonists. A recent summary of mechanisms viruses use to block
the IFN response clearly illustrates that some viral proteins target
more than one step in the pathway (e.g. influenza virus NS1) and
some viruses encode more than one IFN antagonist (e.g.
paramyxovirus V, C, and N proteins), exemplifying the impor-
tance of IFN signaling to host defense [1,9].
Signal transduction pathways that activate IRF3 and NFkB
have been well studied in the context of the virus-induced IFN
response. Upon virus detection, IRF3 is phosphorylated at its C
terminus by kinases TBK1 or IKKe [10], dimerizes and then
translocates to the nucleus to assemble at the IFNb promoter and
select ISRE-containing promoters in cooperation with transcrip-
tion co-activators [8]. IRF3 activation is required for IFNb
transcription, and the number of reports of viruses that interfere
directly with the function of IRF3, or the steps preceding its
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the hepatitis C virus NS3-4A protease complex cleaves TLR3
adaptor protein TRIF, blocks RIG-I signaling and cleaves adaptor
protein IPS (also known as MAVS/Cardif/VISA) to release it
from the mitochondrial membrane, consequently blocking IRF3
activation [4,11]. One of the more recently defined viral IFN
antagonists is rotavirus nonstructural protein NSP1. NSP1 targets
IRF3, IRF5, and IRF7 for proteasome-dependent degradation
early post-infection [12,13,14]. By targeting IRFs for degradation,
NSP1 enhances rotavirus cell-to-cell spread in vitro [12].
NFkB is required for induction of IFNb transcription, although
exceptions to the requirement for NFkB under select experimental
conditions have been reported [15,16]. NFkB is activated by
numerous stimuli, and in addition to regulating gene expression
associated with innate and adaptive immune responses, functions
in signaling pathways that control cell division and apoptosis [17].
NFkB subunits are held inactive in the cytoplasm by association
with inhibitors of kB( I kB). Phosphorylation of IkBb yI kB kinases
(IKKa/b) results in its rapid ubiquitination by the E3 ligase Skp1/
Cul1/F-box complex, SCF
b-TrcP, and subsequent degradation by
the 26S proteasome [18]. IkB degradation releases the p50/relA
(p65) heterodimer, which translocates to the nucleus for promoter
binding and transcription of NFkB target genes. Multiple steps in
the NFkB pathway are targets for viral IFN antagonists, some of
which are common to the IRF3 activation pathway [19].
Rotaviruses cause severe gastroenteritis in infants and young
children, and in newborns of most mammalian species [20]. The
rotavirus genome consists of 11 segments of dsRNA encoding six
structural proteins and six nonstructural proteins. Nonstructural
protein NSP1 is the least conserved protein among different
strains; however, a zinc-binding domain comprised of a specific
pattern of cysteine and histidine residues near the amino terminus
is invariant [21]. Results from our laboratory and others have
shown that NSP1 from several different rotavirus strains targets
IRF3 for proteasome degradation early post-infection. Expression
of NSP1 in the absence of infection directs IRF3 degradation,
indicating it is the sole viral protein that mediates this effect. NSP1
of simian rotavirus also directs proteasome-mediated degradation
of IRF5 and IRF7 [13]. Investigation into the properties of NSP1
responsible for IRF3 degradation showed the conserved zinc finger
domain is required for this activity [14].
Modification of eukaryotic proteins with ubiquitin (Ub) prior to
proteasome degradation requires an E1 activating enzyme, E2
conjugating enzyme, and an E3 ligase that transfers Ub from E2 to
the target substrate [22]. E3 ligases fall into two major classes of
proteins that contain either a catalytic HECT domain or a RING
domain. Typical RING domains consist of cysteine and histidine
residues spaced in a C3HC4 pattern that coordinately bind two
zinc ions [23], yet evidence is accumulating that variations of the
C3HC4 pattern exist in the RING superfamily [24]. Viral proteins
with cysteine-histidine rich zinc binding domains have demon-
strated E3 ligase activity, and many of the cellular targets of viral
E3s are associated with regulation of immune responses to
infection [25]. The pattern of cysteine and histidine residues in
the zinc finger motif of NSP1 is similar, but not identical, to RING
finger domains in cellular E3 ubiquitin ligases. Thus we proposed
that NSP1 contained a variant RING domain signature and
functioned as a viral E3 ubiquitin ligase that targets proteins with
roles in the IFN signaling pathway as substrates for proteasome
degradation [14].
We recently reported that IRF3 was activated and stable in cells
infected with porcine rotavirus strain OSU [14]. Therefore, we
sought to determine if an alternative mechanism to block
induction of IFNb was encoded in the rotavirus genome. The
studies reported herein revealed that NFkB activation was blocked
in OSU infected cells due in part to stabilization of phosphorylated
IkBa. Dissection of the steps involved in IkBa degradation
revealed that the substrate recognition protein, b-transducin
repeat containing protein (b-TrCP), of the cellular E3 ubiquitin
ligase complex SCF
b-TrcP is targeted for proteasome degradation
by NSP1. The SCF
b-TrCP E3 ligase is responsible for ubiquitina-
tion of IkBa [26,27], thus providing an explanation for IkBa
stabilization and the lack of NFkB activation in infected cells.
Targeted degradation of a cellular F-box protein required for E3
ligase substrate recognition is a novel IFN evasion strategy, and
defines a second mechanism of interference with the innate
immune response encoded in the rotavirus genome.
Results
IRF3 accumulates in the nucleus of OSU infected cells
IRF3 is phosphorylated in OSU infected MA104 cells,
indicating that the virus is detected and signaling pathways
leading to IRF3 phosphorylation are intact. Once phosphorylated,
IRF3 dimerizes and translocates to the nucleus to assemble with
transcription co-activators on the IFNB promoter as well as ISRE-
containing promoters. To test whether these latter steps in the
activation pathway were affected by OSU infection, the cellular
distribution of IRF3 was analyzed by IF microscopy (Figure 1A).
Bovine rotavirus strains A5-16 and NCDV also were analyzed in
these experiments for comparison with OSU because the behavior
of these strains with respect to IRF3 activation has been described.
A5-16 encodes a truncated NSP1 [28], and IRF3 is phosphory-
lated and stable in A5-16 infected cells [14]. NCDV encodes an
NSP1 that binds to and targets IRF3 for proteasome degradation
[14,29]. The microscopy revealed that IRF3 was diffusely
distributed in the cytoplasm in mock infected cells. In A5-16
infected cells, IRF3 accumulated in the nucleus as expected. IRF3
also accumulated in the nucleus of OSU infected cells, indicating
nuclear translocation is not inhibited in MA104 cells infected with
this rotavirus strain. IRF3 was not detected at all in NCDV
infected cells, consistent with its degradation early post-infection.
Author Summary
Cells respond to virus infection by inducing a pattern of
gene expression regulated by interferon (IFN) that
modulates the host immune response. In order to
successfully replicate, viruses have evolved mechanisms
to block the induction or function of IFN and IFN-regulated
genes. Multiple proteins are activated in the cell when
virus infection is detected, and it is these steps upstream of
IFN synthesis that are commonly inhibited by virally
encoded proteins. In this study, we investigated the
function of a rotavirus protein known to block IFN
responses. Rotaviruses cause life-threatening gastroenter-
itis in infants and young children and are responsible for
substantial morbidity and mortality worldwide. Here we
show that the rotavirus protein NSP1 blocks the function
of cellular protein b-TrCP by inducing its degradation. b-
TrCP is a component of a multisubunit complex important
in the proteasome degradation pathway and is required
for activation of transcription factor NFkB, which is
necessary for expression of IFN and IFN-regulated genes.
This is a unique strategy for viral evasion of host immune
responses. Identification of viral IFN antagonists is
important to understanding how best to induce cellular
responses that can override viral evasion strategies and
help reduce spread of infection in the host.
NSP1 Targets b-TrCP for Proteasome Degradation
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the block is mediated by NSP1
The presence of nuclear IRF3 led us to test whether IFNb
mRNA was synthesized in cells infected with each of the three
strains. IFNb was strongly induced in A5-16 infected cells as
expected, but not in NCDV or OSU infected cells (Figure 1B).
The lack of IFNb mRNA in NCDV infected cells can be explained
by degradation of IRF3, but nuclear IRF3 in OSU infected cells
suggested an alternative mechanism was used by this virus to block
IFNb transcription.
NSP1 encoded by rotavirus strains analyzed thus far directs
proteasome-mediated degradation of IRF3 when expressed in the
absence of infection. To determine whether NSP1 encoded by
OSU played a role in inhibiting IFNb transcription, 293-TLR3
cells [39] were transfected with a plasmid encoding OSU NSP1
(pO-NSP1) or NCDV NSP1 (pN-NSP1), and a reporter plasmid
encoding firefly luciferase under control of the IFNb promoter.
Cells then were treated with polyI:C to induce reporter gene
expression. Expression of OSU NSP1 inhibited polyI:C-induced
luciferase expression by ,20-fold compared to cells transfected
with empty vector (Figure 1C). Reporter expression in cells
expressing NCDV NSP1 was inhibited ,30-fold; a substantial
portion of this reduction can be attributed to the lack of IRF3. We
note that the basal levels of luciferase expression induced by each
plasmid in the absence of polyI:C treatment showed a similar
pattern; that is, luciferase expression was inhibited when cells
Figure 1. Induction of IFNb is blocked during OSU infection, and the block is mediated by NSP1. (A) Subcellular localization of IRF3 in
MA104 cells infected with three pfu/cell of the indicated virus strain was determined six hours post-infection (hpi) by IF microscopy (406, NA 0.75).
Fixed cells were stained with anti-IRF3 monoclonal antibody followed by Alexa Fluor 488-conjugated goat anti-mouse IgG. Nuclei were visualized by
DAPI staining. (B) Induction of IRF3-regulated genes was analyzed by RT-PCR using RNA collected eight hpi from MA104 cells infected with three pfu/
cell of the indicated virus strain. Actin mRNA was used as a template loading control. (C) 293-TLR3 cells were co-transfected with pN-NSP1 (NCDV) or
pO-NSP1 (OSU), Renilla luciferase reporter plasmid phRL-CMV (Promega) and IFNb-Luc. Forty hours post-transfection, the cells were treated with
100 mg/mL polyI:C , and lysates were prepared eight hours post-treatment. Reporter activity was measured with the Dual Luciferase Assay System
(Promega). Data are represented as fold-inhibition of IFNb reporter induction normalized to cells transfected with empty expression vector. Error bars
indicate the SEM.
doi:10.1371/journal.ppat.1000280.g001
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prominent for OSU NSP1. These results demonstrate that OSU
NSP1 inhibits IFNb promoter-driven gene expression in the
absence of infection, and without an obvious mechanism to
interfere with the function of IRF3.
Recent studies defined a hyperphosphorylated form of IRF3
that translocates to the nucleus but is degraded, and therefore is
transcriptionally inactive [30]. The transcriptional activity of
nuclear IRF3 was examined by RT-PCR of IP-10, ISG56, and
IFNb mRNA. IRF3-regulated genes IP-10 and ISG56 have
different transcription factor requirements for expression. While
IFNb and IP-10 generally require both IRF3 and NFkBw i t h
noted exceptions [15,16], IRF3 is sufficient to induce ISG56
[31]. IP-10 and ISG56 mRNA were analyzed by RT-PCR to
further dissect the activity of transcription factors required for
expression of these genes in infected cells. A5-16 induced
transcription of both IP-10 and ISG56, but neither were induced
in NCDV infected cells (Figure 1B). In contrast, OSU infection
induced ISG56, but not IP-10. The fact that ISG56 was induced
in OSU infected cells confirmed that nuclear IRF3 is
transcriptionally active. Likewise, the lack of IP-10 induction
suggested OSU may encode a mechanism to block activation of
NFkB.
NFkB activation is inhibited in OSU infected cells, and the
block is mediated by NSP1
NFkB activation in OSU infected cells first was evaluated with
the p50 TransAM ELISA, which measures phosphorylated p50
subunit binding to DNA. MA104 cells were infected with A5-16,
NCDV, or OSU, and whole cell lysates were harvested six hours
post infection (hpi). The amount of activated p50 was significantly
higher in A5-16 and NCDV infected cell lysates compared to
lysates from mock infected cells (Figure 2A and Figure S1A). By
contrast, the amount of activated p50 in OSU infected cell lysates
was not different from mock infected controls. The NFkB p50
subunit most commonly forms a p65-p50 heterodimer with
transactivation activity [25]. However, p50 also forms homodi-
mers that act as repressors when bound to promoters because the
p50 subunit lacks a transactivation domain [32]. The ELISA did
not detect elevated levels of p50 capable of binding DNA in OSU
infected cells, indicating that infection did not induce formation of
the activated p65-p50 heterodimer or the inhibitory p50
homodimer.
Given the previously defined role for NSP1 in IRF degradation,
we asked whether NSP1 played a role in modulating the activity of
NFkB. 293-TLR3 cells were co-transfected with pO-NSP1 or pN-
NSP1, and a luciferase reporter plasmid that contained tandem
Figure 2. Inhibition of NFkB activation in OSU infected cells is mediated by NSP1. (A) MA104 cells were infected with 10 pfu/cell of the
indicated virus strain, and cell lysates were prepared six hpi. NFkB subunit p50 binding to kB sites was determined by the TransAM p50 ELISA. Data
are represented as the mean OD450 nm value from three independent experiments. Error bars indicated the SEM. p-values were determined by
unpaired Student’s t-test (asterisk=p,0.01). (B) 293-TLR3 cells were transfected with pN-NSP1 (NCDV) or pO-NSP1 (OSU), Renilla luciferase reporter
plasmid phRL-CMV, and pNFkB-Luc Cis. Forty hours post-transfection, cells were treated with 100 mg/mL polyI:C for eight hours, and then reporter
activity in the lysates was measured with the Dual Luciferase Assay System. Data are represented as fold inhibition of NFkB reporter induction
normalized to cells transfected with the empty expression vector. Error bars indicated the SEM.
doi:10.1371/journal.ppat.1000280.g002
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polyI:C, and reporter expression was analyzed by luciferase assay
(Figure 2B). Expression of OSU NSP1 resulted in ,20-fold
inhibition of NFkB promoter-driven reporter gene expression
relative to cells transfected with the empty vector. A five-fold
inhibition of luciferase expression was observed in cells
expressing NCDV NSP1, indicating some degree of NFkB
inhibition by this strain. Previously, we showed that OSU NSP1
accumulates to higher levels than NCDV NSP1 in transfected
293 cells. Immunoblot analysis of cell lysates used for the
luciferase reporter experiments showed that NCDV NSP1 and
OSU NSP1 were expressed at equal levels (Figure S2), indicating
the difference in fold-inhibition between NSP1 of these two
strains is not due to differences in levels of expression. Taken
together, these data suggested that a predominant mechanism of
IFN antagonism in OSU infected cells was interference with
activation of NFkB, and that OSU NSP1 alone could mediate
this effect. Moderate inhibition of NFkB activation in NCDV
infected cells and NCDV NSP1-expressing cells also was
observed. However, data from the p50 DNA binding ELISA
and reporter gene assay together suggest NCDV is less efficient
than OSU in blocking activation of NFkB.
Localization and activation of NFkB subunit p65
The fact that IRF3 is targeted for proteasome degradation by
some rotavirus strains led us to test whether degradation of NFkB
subunits was responsible for the block to NFkB activation. Whole
cell lysates from mock infected and infected cells were collected
every two hours for ten hours, and the abundance of p65
(Figure 3A) and p50 (data not shown) was analyzed by
immunoblot. The levels of both p65 and p50 in cells infected
with the three viruses were equal to the level detected in mock
infected cells, indicating that degradation of these subunits was not
induced by any of the virus strains tested.
Inhibition of NFkB reporter activation and stability of NFkB
subunits in OSU and NCDV infected cells led us to test whether
p65 was transcriptionally functional. Cells were mock infected or
infected as before, and activated p65 in nuclear fractions was
measured with the p65 TransAM ELISA. Consistent with the
reporter assays, the amount of activated p65 in OSU and NCDV
infected cells was significantly less than that in A5-16 infected cells
(Figure 4A). The amount of nuclear p65 also was measured by
immunoblot (Figure 4B). The results indicated that the highest
amount of p65 was present in the A5-16 fractions, consistent with
induction of NFkB dependent gene expression in A5-16 infected
cells. In contrast, very little p65 was detected in fractions from
OSU and NCDV infected cells. The cytoplasmic carryover in the
fractions of all the samples shown by the presence of GAPDH is
nearly identical, including the mock infected control. While these
data do not quantitatively assess the amount of p65 that
translocates to the nucleus compared to what remains in the
cytoplasm, the relative amounts of p65 in each fraction can be
compared, and clearly illustrate the significant difference between
the amount of p65 present in A5-16 lysates and lysates from OSU
and NCDV infected cells.
The lack of p65 activation and the low amounts of p65 in the
nucleus of OSU and NCDV infected cells led us to further
evaluate the subcellular localization by IF microscopy. MA104
cells were infected for six hours with A5-16, NCDV or OSU, and
p65 was localized by staining with an anti-p65 antibody
(Figure 3B). p65 was distributed in a diffuse pattern throughout
the cytoplasm in mock infected cells as expected. In A5-16 and
NCDV infected cells, nuclear staining of p65 was evident,
indicating some degree of translocation occurred. p65 localization
in OSU infected cells was distinct, as it was detected in the nucleus
at very low levels and only in filament-like structures that were
inconsistent with the typical distribution pattern displayed by p65
in transcriptionally active complexes. The vast majority of p65 in
Figure 3. NFkB subunit p65 is stable in rotavirus infected cells. (A) MA104 cells were infected with three pfu/cell of the indicated virus strain.
Lysates were prepared at 2, 4, 6, 8, and 10 hpi and the abundance of p65 was determined by immunoblot using anti-p65 antibody. Blots were probed
with anti-GAPDH as a loading control. (B) The subcellular localization of p65 in MA104 cells infected with three pfu/cell of the indicated virus strain
was determined at six hpi by confocal microscopy (636, NA 1.40). Cells were stained with anti-p65 antibody, followed by Alexa Fluor 594-conjugated
goat anti-rabbit IgG.
doi:10.1371/journal.ppat.1000280.g003
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perinuclear structures that also were observed, but to a lesser
extent in A5-16 and NCDV infected cells. These structures were
reminiscent of viroplasms formed in rotavirus infected cells,
where genome replication, packaging and particle assembly
occur. Double staining with anti-p65 and an antibody to
structural protein VP6, and analysis by confocal microscopy
showed these two proteins co-localized in infected cells,
suggesting p65 that does not translocate to the nucleus is
associated with viroplasms (Figure S3A, Protocol S1). Co-
immunopreciptation of viral proteins with p65 confirmed this
association (Figure S3B). The observed filament structures in the
nucleus resembled actin fibers formed in the nucleus of
herpesvirus infected cells [33], but their origin was not further
investigated in this study.
IkBa is stable in OSU and NCDV infected cells
Phosphorylation of IkBa and subsequent ubiquitination and
proteasome degradation is required for activation of NFkB. To
assess the activation status of IkBa, lysates from cells infected with
each of the three virus strains were prepared every two hours for
ten hours, and IkBa was analyzed by immunoblot. IkBa was
substantially degraded by six hpi in A5-16 infected cells
(Figure 5A), but stable in the presence of MG132, confirming
proteasome-dependent degradation (Figure S4). By contrast, IkBa
was detected in lysates from NCDV and OSU infected cells
through the ten hour time point. Although IkBa was present at
each time point through the conclusion of the time course, analysis
of band intensities by densitometry from three independent
experiments indicated that IkBa was present in NCDV and
OSU infected lysates at levels approximately 50% of the mock
infected controls (Figure 5B). Therefore, some IkB degradation
does occur, most likely prior to accumulation of levels of viral
protein sufficient to block this activity.
IkBa is phosphorylated by the IKK complex on serine residues
32 and 36, resulting in recognition and ubiquitination by the
SCF
b2TrCP E3 ubiquitin ligase complex [18,34]. To distinguish
between a block to phosphorylation of IkBa and a block to
subsequent proteasome degradation, immunoblots were probed
with an antibody that recognizes the phosphorylated form of IkBa
(p-IkBa, Figure 5C). Phosphorylated IkBa was not detected at any
time during the infection with A5-16 because this form is rapidly
degraded. In OSU and NCDV infected cells, p-IkBa accumulated
through ten hpi, with peak accumulation observed at 4–6 hpi. The
presence of p-IkBa indicated that activity of the IKK complex was
not disrupted by either of these viruses, and that proteasome-
mediated degradation of IkBa is inhibited by both.
Degradation of IkBa is rapidly induced in cells treated with
TNFa. To determine if IkBa was stable in cells when the stimulus
was not virus infection, and to confirm that p-IkBa was stable, we
tested whether TNFa induced IkBa degradation in infected cells.
MA104 cells were mock infected or infected for eight hours, and
then treated with TNFa for 15 minutes. Cell lysates then were
probed with antibody to total IkBa or to p-IkBa. The results
revealed that upon treatment with TNFa,I kBa was phosphory-
lated and stable in NCDV and OSU infected cells, but not in
mock infected cells (Figure 5D). These data show that treatment
with a strong inducer of NFkB does not overcome the virus
infection-associated block in this signaling pathway, and further
support the conclusion that IkBa degradation is actively inhibited
in OSU and NCDV infected cells.
F-box protein b-TrCP is degraded in OSU and NCDV
infected cells
The SCF
b-TrCP E3 ligase complex mediates proteasome-
dependent degradation of several proteins with roles in regulating
cell proliferation, including IkBa,N F kB subunits p100 and p105,
cyclin dependent kinases, and b-catenin, among others [35].
SCF
b-TrCP is a negative regulator of the Wnt/b catenin signaling
pathway, and as such, expression of dominant negative mutants of
b-TrCP results in accumulation of b-catenin [36]. We reasoned
that if SCF
b-TrCP was nonfunctional in infected cells, b-catenin, in
addition to IkBa, would accumulate to a level higher than that in
mock infected controls. The amount of b-catenin in OSU infected
cells at ten hours post infection was consistently higher than mock
infected cells, suggesting activity of SCF
b-TrCP was impaired
(Figure S5).
To test the theory that SCF
b-TrCP may not be functional in
OSU and NCDV infected cells, 293 cells were transfected with a
plasmid encoding a Flag-tagged b-TrCP, and then infected with
the three strains as in prior experiments. Immunoblots were
probed with anti-Flag antibody to detect b-TrCP, or NSP1
polyclonal antibody. In A5-16 infected cells, b-TrCP was present
in approximately the same amounts as the transfected, uninfected
control (Figure 6A). b-TrCP was not detected in either NCDV
infected cells or OSU (input panel) infected cells. These data led us
to suspect that b-TrCP may be targeted to the proteasome in cells
infected with these two strains. To address this question, cells were
transfected with Flag-b-TrCP, and then infected in the presence of
proteasome inhibitor MG132. Immunoblots were probed with
Figure 4. p65 activation and nuclear translocation. MA104 cells were infected with A5-16, OSU or NCDV at an moi of three pfu/cell. Six hours
post-infection, nuclear and cytoplasmic fractions were separated with the nuclear extract kit following the manufacturer’s instructions (Active Motif).
(A) p65 activation measured by p65 TransAm ELISA. Error bars are the standard error of the mean. (B) Nuclear fractions were probed with anti-p65
antibody, anti-laminA/C (nuclear, BD Biosciences), and anti- GAPDH (cytoplasmic) antibodies.
doi:10.1371/journal.ppat.1000280.g004
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proteasome activity is inhibited, b-TrCP is stable in infected cells
(Figure 6B). The fact that b-TrCP was stable in cells infected with
A5-16 in the absence of MG132, suggested that NSP1 played a
role in this process.
NSP1-directed degradation of IRF3 requires an interaction
between the two proteins. We tested whether NSP1 interacted
with b-TrCP. 293 cells were co-transfected with plasmids encoding
NSP1 and Flag-b-TrCP in the presence of MG132, and co-
immunoprecipitations were performed with anti-Flag antibody,
followed by immunoblot with either anti-Flag or anti-myc
antibody to detect NSP1. NSP1 of both OSU and NCDV co-
immunoprecipitated with b-TrCP when cells were treated with
MG132 to protect b-TrCP from degradation (Figure 7). We note
that b-TrCP is not detected in the input lanes even in the presence
of MG132, in contrast to the data shown in Figure 6B. We believe
this is a consequence of the experimental conditions, in that an
eight hour treatment with MG132 is insufficient to allow b-TrCP
to accumulate to detectable levels when it is co-expressed with
NSP1 for 40 hours prior to addition of the proteasome inhibitor.
The immunoprecipitation reactions in this case effectively
concentrate the amount of b-TrCP remaining so that it is detected
in complex with NSP1. In addition, there is an obvious difference
in the amount of OSU NSP1 present in cells that were co-
transfected with b-TrCP compared to those transfected with the
NSP1 plasmid alone (Figure 7, pO-NSP1 input lanes), such that
NSP1 appears stabilized in the presence of b-TrCP. We have
observed an increase in the levels of expression of both NSP1 and
EYFP when this construct is co-transfected with the b-TrCP
plasmid. The reasons for the increase are not known, but as shown
by the data in Figure 6, the presence of b-TrCP has no effect on
the levels of NSP1 synthesized in native virus infected cells. The
interaction between NSP1 and b-TrCP was confirmed to occur in
OSU infected cells by co-immunoprecipitation of NSP1 with b-
TrCP from Flag-b-TrCP expressing cells (see Figure 6A, IP panel).
Discussion
It is clear that viruses encode proteins that down-regulate
cellular immune responses, yet the strategies are disparate, and
include interference with both innate and adaptive pathways. We
report a novel immune evasion mechanism in which a viral
nonstructural protein targets the substrate recognition component
of a multisubunit cellular E3 ligase for proteasome degradation. At
least one functional consequence of b-TrCP degradation relevant
to induction of the innate immune response is inhibition of NFkB
activation and IFNa/b expression. However, SCF
b-TrCP also
regulates stability of proteins involved in control of cell
proliferation including b-catenin, Emi1, and cyclin dependent
kinases, among many others [35]. As such, over-expression of b-
TrCP and consequent constitutive activation of NFkB has been
reported in several tumor cell lines [37,38,39,40]. It stands to
Figure 5. IkBa is stable in cells infected with strains that encode NSP1. (A) MA104 cells were infected with three pfu/cell of the indicated
virus strain and lysates were prepared every two hours for ten hours. Immunoblots were probed with anti-IkBa antibody. All blots were probed with
anti-GAPDH antibody as a loading control. (B) IkBa levels were quantified by densitometry and are plotted as the ratio of IkBa to GAPDH, normalized
to mock infected control. Error bars are the standard error of the mean. (C) Immunblot of lysates in (A) probed with anti-p-IkBa antibody (D) MA104
cells were infected with three pfu/cell of the indicated virus strain. Eight hours post-infection, cells were treated with 50 ng/mL TNFa for 15 minutes.
Immunoblots were probed with anti-IkBa or anti-p-IkBa, and anti-GAPDH antibodies. IkBa is not detectable in A5-16 infected cells because it is
degraded by six hours post-infection (see panel A).
doi:10.1371/journal.ppat.1000280.g005
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absence of b-TrCP on the proliferative state of the cell also may
play a role in modulating virus replication. Blocking NFkB
activation in response to cell stress will result in amplification of a
pro-apoptotic response. Several studies have shown that rotavirus
infection induces apoptosis both in vitro and in vivo, and
Figure 7. NSP1 expressed in isolation binds to and induces degradation of b-TrCP. 293 cells were co-transfected with pFlag-b-TrCP and
either pN-NSP1 or pO-NSP1. Forty hours post-transfection, MG132 was added to the media to a final concentration of 10 mM and the cells were
incubated an additional eight hours. 10% of each sample was set aside as input and the remaining lysate was subjected to immunoprecipitation with
anti-FLAG M2 Agarose Affinity Resin (Sigma). Immunoblots were probed with anti-Flag and anti-myc (NSP1 detection) antibodies.
doi:10.1371/journal.ppat.1000280.g007
Figure 6. Rotavirus strains that express NSP1 induce proteasome-mediated degradation of b-TrCP. (A) 293 cells were transfected with
Flag-tagged b-TrCP (pFlag-bTrCP) and then infected with three pfu/cell of the indicated virus strain. Cell lysates were prepared eight hpi, and
immunoblots were probed with anti-Flag antibody (top panel); anti-Flag and anti-NCDV NSP1 antibody (middle panel); or anti-Flag and anti-OSU
NSP1 (bottom panel, Input). In the bottom right panel, the lysate from b-TrCP expressing, OSU infected cells was subjected to immunoprecipitation
with anti-Flag M2 Agarose Affinity Resin, and blots were probed with anti-Flag antibody or anti-OSU NSP1 antibody (B) The same experiment as
described in (A), except that proteasome inhibitor MG132 was added at the time of virus infection to final concentration of 10 mM.
doi:10.1371/journal.ppat.1000280.g006
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pathway, have been reported [41,42,43]. Together, the data
suggest that inducing apoptosis may be advantageous for rotavirus
replication and spread, and it remains to be determined whether
blocking apoptosis will affect virus spread or progeny production.
While targeted degradation of b-TrCP by NSP1 is unique, viral
manipulation of the ubiquitin-proteasome system is not [25].
Some viral proteins modulate the ubiquitin-proteasome system by
redirecting cellular E3 ligases to alternative substrates or directly
interfering with their function. For example, V proteins of some
viruses in the Paramyxoviridae target STAT1 and/or STAT2 for
proteasome degradation, thus preventing assembly of ISGF3
[44,45,46]. IRF7 is required for a maximal IFN response and is a
substrate for the Kaposi’s sarcoma herpesvirus (KSHV) RTA
ligase [47]. Herpes simplex virus protein ICP0 has been well
characterized, and induces proteasome-dependent degradation of
the stress-related kinase DNA-PK [48] and promyelocytic
leukemia protein [49,50]. Viral infectivity factor (VIF) encoded
in the HIV genome forms a ligase complex through interactions
with the RING domain-containing protein Rbx1/Roc1, and
recruits APOBEC3G as a substrate for ubiquitination, thus
functioning as an F-box protein surrogate in cellular complexes
[51].
Another HIV protein that manipulates the ubiquitin-dependent
proteasome system and is particularly relevant to the work
reported here is Vpu, most noted for its role in directing
degradation of CD4 [52]. Vpu binds CD4 and b-TrCP, resulting
in polyubiquitination of CD4 and proteasome degradation, but
Vpu itself is not degraded through this interaction [52]. It has been
suggested that Vpu blocks NFkB activation in infected cells by
acting as a competitive inhibitor for b-TrCP binding, and
consequently stabilizes IkB [52]. NSP1-dependent proteasome-
mediated degradation of b-TrCP reveals a new mechanism for
interfering with the function of this protein. It is now evident that
major players in immune response signaling networks are targeted
by viruses in several families, and therefore, consideration of b-
TrCP as another important target of IFN antagonism by multiple
viruses seems warranted.
The conserved N-terminal cysteine-histidine rich region of
NSP1 does not conform to standard RING domain signatures.
However, mutational analysis has shown that cysteine and
histidine residues in this region are required to direct IRF3
degradation in transfected cells [14]. Direct evidence of intrinsic
E3 ligase activity of NSP1 has not yet been reported, and in this
context, it is appropriate to consider the mechanism by which
NSP1 ‘‘hijacks’’ the cellular ubiquitination machinery and directs
proteasome degradation of selected substrates. RING domain-
containing E3 ligases are either unimolecular or multisubunit, and
viral E3 ligases exist in both categories [25]. Unimolecular E3s
recruit the cognate E2 through a RING domain, and the substrate
through protein-protein interactions in a separate domain of the
molecule. Single subunit E3s include cellular proteins c-Cbl [53],
Mdm2 [54], and XIAP [55], and viral proteins RTA [47]and
ICP0 [56], all of which are relatively large proteins of .450 amino
acids. In multisubunit ligases such as SCF
b-TrCP, the RING
domain protein Rbx1/Roc1 is ,100 amino acids and the
substrate recognition component is a separate protein in the
complex. NSP1 could assemble in SCF complexes, thus function-
ing as the substrate recognition component and RING finger
protein of a multisubunit E3. The molecular weight of NSP1
(,490 amino acids) and predicted structure is most consistent with
single subunit E3s, and we recently reported that NSP1 regulates
its own stability in a proteasome-dependent manner [14]. This
auto-regulatory capability is characteristic of unimolecular cellular
and viral E3s that have experimentally defined intrinsic ligase
activity [53,54]. A refined definition of the mechanism by which
NSP1 functions in the ubiquitin-dependent proteasome pathway
requires study of additional cellular interaction partners, including
those specifically associated with ubiquitin ligase complexes.
Likewise, the motifs in cellular proteins that dictate their
recognition as NSP1 substrates are not known, and determining
the range of activity of NSP1 will be important to decipher.
Since we had observed that IRF3 was activated in OSU infected
cells but IFNb transcription still was inhibited, we expected an
alternative mechanism was operational and independent of IRF3.
The discovery that b-TrCP was degraded in NCDV infected cells
as well was unexpected, but not wholly surprising, because
redundancy in mechanisms of viral interference with IFN signaling
is well documented. NFkB activation was inhibited in NCDV
infected cells, but the magnitude was much less than that observed
in OSU infections. Therefore, IRF3 degradation in NCDV
infected cells may be the dominant and most efficient mechanism
of NSP1-mediated IFN antagonism for this strain, and perhaps
other strains known to target IRF3. In contrast, OSU NSP1 does
not strongly bind IRF3 in these cells lines, and inhibition of NFkB
activity by degradation of b-TrCP is dominant. Substrate
specificity of NSP1 thus may define the prominent mechanism
of IFN antagonism in different rotavirus strains.
The results of these studies also suggest rotaviruses utilize more
than one mechanism to down-regulate NFkB-dependent gene
expression that is independent of NSP1. There is similarity in the
localization of p65 to viroplasms in cells infected with each virus,
including A5-16 which does not encode NSP1, the obvious
difference being that nuclear accumulation of transcriptionally
active p65 in OSU infected cells was nearly completely blocked.
This observation suggests OSU is more efficient at sequestering
p65 in the cytoplasm and by extension, inhibiting NFkB
activation, than NCDV and A5-16. Sequestration of an NFkB
subunit in viroplasms and interactions with viral structural proteins
is a novel observation. We have shown that p65 co-immunopre-
cipitates with at least three rotavirus proteins, and it will be of
interest to determine the role of these proteins in the altered
distribution of p65. It is possible that the degree of p65
sequestration depends on strain specific differences in kinetics or
efficiency of viroplasm formation in infected cells.
NFkB-dependent cytokine induction and microarray data have
shown increased expression of NFkB-regulated genes during
rotavirus infection [57,58]. Our data generally are not in conflict
with these results. We observe moderate degradation of IkBa in
both OSU and NCDV infected cells at early times post-infection,
and it is plausible that some NFkB-dependent gene expression is
induced. This makes sense given the time-lapse between activation
of signal transduction pathways and accumulation of NSP1 in the
cell. In this context, viral interference with these pathways
functions to down-regulate the response instead of blocking its
initial induction. Other rotaviruses reported so far to activate
NFkB include among others, simian and rhesus strains that target
IRF3 for degradation. Although we have not determined whether
NFkB is activated in cells infected with these strains, we predict
activity similar to NCDV. Continued analysis of the ways multiple
rotavirus strains modulate the NFkB pathway will test this
prediction.
Use of viruses that are unable to block IFN responses is
becoming an attractive approach to development of attenuated
virus vaccines [1,59,60,61,62,63]. Generation of rotavirus vaccines
containing strains with mutations within NSP1 may result in
additional vaccine formulations that consist of attenuated virus
isolated from homologous hosts. In this context, careful analysis of
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will be important for future studies.
Materials and Methods
Cells, viruses, and NSP1 expression plasmids
MA104 cells were grown in M199 media (Mediatech)
supplemented with 5% FBS (Atlanta Biologicals). HEK293 cells
were grown in RPMI 1640 media (Mediatech) supplemented with
10% FBS, 10 mM HEPES, 16nonessential amino acids, 2 mM
L-glutamine, and 1 mM sodium pyruvate. 293-TLR3 cells (kindly
provided by Dr G. Sen, Cleveland Clinic, Cleveland, OH), were
grown in the same conditions as 293 cells, except that the media
was supplemented with 400 mg/mL of G418.
Isolation and characterization of rotavirus strains A5-16,
NCDV, and OSU has been described [28,64,65,66]. To
prepare virus stocks, MA104 cells were infected at a multiplicity
of infection (MOI) of 0.05, and harvested when ,95%
cytopathic effect was observed. Culture media was clarified of
cell debris by centrifugation at 20006g for 10 minutes, and the
virus in the supernatant was concentrated by centrifugation at
26,000 rpm in an SW28 rotor (Beckman) for two hours at 4uC.
Virus pellets were suspended in serum-free M199, and stored in
aliquots at 280uC. Virus titers were determined by standard
plaque assay.
Construction of expression plasmids encoding OSU NSP1 (pO-
NSP1) and NCDV NSP1 (pN-NSP1) has been described [14]. A
myc epitope tag is fused to the NSP1 coding sequence of both for
detection by immunoblot.
RT-PCR
MA104 cells were infected with trypsin-activated virus at an
MOI of three pfu/cell in serum-free M199. Eight hours post-
infection (hpi), total cell RNA was extracted using TRIzol reagent
(Invitrogen). RNA was treated with ten units of DNAse for
30 minutes at 37uC, and then extracted with phenol/chloroform.
Reverse transcription reactions were performed with random
hexamers (Promega) and Superscript II reverse transcriptase
(Invitrogen), incubated for 50 minutes at 42uC. PCR reactions
were performed with Taq polymerase (Promega). Gene-specific
primers included: IFNb (forward 59 - CTC CTC CAA ATT GCT
CTC CTG – 39; reverse 59 – GCA AAC TGC TCA CGA ATT
TTC C – 39), ISG56 (forward 59 – AAC ACC TGA AAG GCC
AGA ATG AGG-39; reverse 59 – AAG ACA GAA GTG GGT
GTT TCC TGC-39), IP-10 (forward 59 – CTG CGA TTC TGA
TTT GCT GCC – 39; reverse 59 – GGA GAT CTT TTA GAC
ATT TCC TTG CTA ACT GC – 39), and b-actin (forward 59 –
CAT GTT TGA GAC CTT CAA CAC – 39; reverse 59 – CAT
CTC CTG CTC GAA GTC TAG – 39).
Reporter gene assays
293-TLR3 cells were transfected using TransIT-293 Transfec-
tion Reagent (Mirus) according to the manufacturer’s instructions.
The luciferase control plasmid phRL-CMV was purchased from
Promega. IFNb-Luc was kindly provided by Dr J. Hiscott, McGill
University, Montreal, Quebec, CA, and pNFkB-Luc Cis Reporter
Plasmid was purchased from Stratagene. Forty hours post-
transfection, polyI:C (GE Healthcare) was added to the media at
final concentration of 100 mg/mL. Cell lysates were harvested
eight hours post-treatment and reporter activity was measured
using the Dual Luciferase Assay (Promega) and a Lumat LB 9507
luminometer (EG&G Berthold). Each transfection was performed
in triplicate in two independent experiments.
NFkB activation by TransAm ELISA
NFkB subunit p50 was measured by the p50 TransAM ELISA
(Active Motif). Whole cell extracts were prepared six hpi in Lysis
Buffer AM1. Protein concentration was determined with the RC
DC Protein Assay (Bio-Rad Laboratories) and 20 mg of extract
were used in a TransAM p50 Activation Assay (Active Motif).
Specificity controls provided in both the p50 and p65 assays are
shown in Figure S1. Three independent experiments were
performed and p-values were determined by Student’s unpaired
t-test.
Nuclear p65 was analyzed with the p65 TransAM ELISA.
Nuclear and cytoplasmic fractions were prepared six hpi with the
nuclear extract kit following the manufacturer’s instructions
(Active Motif). Protein concentration was determined with the
RC DC protein assay and five mg of nuclear extract were used in
the assay (Active Motif). Three independent experiments were
performed and p-values were determined by Student’s unpaired t-
test.
Immunoblots
Cell lysates were harvested at the indicated times post-infection
in RIPA buffer (150 mM NaCl, 1% sodium deoxycholate, 1%
Triton X-100, 0.1% SDS, 10 mM Tris-HCl pH 7.2). Immuno-
blots were performed as previously described [23]. Primary
antibodies against the following proteins were used: p65 (Rock-
land), IkBa (Cell Signaling), IkBa phosphorylated on serine 32
(Cell Signaling), GAPDH (Ambion), anti-FLAG (Sigma), anti-
NCDV NSP1 and anti-OSU NSP1. Rabbit polyclonal antiserum
to OSU NSP1 generated against a synthetic peptide near the C
terminus of the protein and was made by Open Bioscience, Inc.
Immunoprecipitations
For immunoprecipitation from infected cell lysates, HEK293
cells were mock transfected or transfected with pCMV-Flag-b-
TrCP2 (kindly provided by Dr. W. Harper, Department of
Pathology, Harvard Medical School, Boston, MA). Twenty hours
post-transfection, the media was changed to serum-free RPMI
1640 and the cells were infected with three pfu/cell of OSU or
NCDV. Cells were harvested eight hpi in 500 mL FLAG
immunoprecipitation lysis buffer (50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1% Triton X-100, 1 mM EDTA) supplemented
with protease inhibitor cocktail (Roche Diagnostics). Lysates were
passed through a 30 gauge needle five times and subsequently pre-
cleared by centrifugation for 10 minutes at 10,0006g. Ten percent
of each sample was set aside as input, and the FLAG-tagged
b2TrCP was immunoprecipitated from the remaining lysate using
anti-FLAG M2-Agarose Affinity Gel (Sigma) according to the
manufacturer’s recommendations. The input and eluted samples
were used in immunoblot analysis using antibodies against FLAG
(Sigma), and OSU NSP1 or NCDV NSP1. Immunoprecipitations
from cells co-transfected with pFlag-b-TrCP and pN- or pO-NSP1
were performed the same way, except that MG132 was added to
the media 40 hours post-transfection, followed by an additional
eight hour incubation.
Immunofluorescence microscopy
MA104 cells were grown in four-well chamber slides (BD
Falcon) and infected with three pfu/cell using rotavirus stocks that
were activated with 10 mg/mL Worthington trypsin for 30 min-
utes at 37uC. Six hpi, the cells were fixed with paraformaldehyde
(2% w/v in PBS) for 10 minutes at room temperature and then
permeabilized with methanol for 10 minutes at 220uC. The
samples were incubated in blocking solution (PBS supplemented
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4uC. Primary antibody diluted in blocking serum was added and
cells were incubated for one hour at room temperature, followed
by three rinses with PBS. The primary antibodies were mouse
anti-IRF3 (Santa Cruz Biotechnology) or rabbit anti-p65 (Rock-
land). The cells were then stained the appropriate Alexa Fluor-
conjugated goat secondary antibodies (Invitrogen) and mounted in
ProLong Gold (Invitrogen) under a glass cover slip. Cells stained
for IRF3 were viewed on an AxioImager.A1 microscope (Zeiss)
using a 406(0.75 NA) objective lens. The images were obtained
using an AxioCam MRc5 camera (Zeiss) and analyzed with the
Axiovision version 4.6.3 (Zeiss) software package. Exposure
parameters were equal for images of each sample. Cells stained
for p65 were viewed on an LSM 510 Meta confocal microscope
(Zeiss) using a 636(1.40 NA) objective lens. Excitation of Alexa
Fluor 594-conjugated secondary antibody was achieved using a
543 nm helium-neon laser. The pinhole was set to 1 Airy unit.
Images were obtained with each line being scanned eight times to
increase the signal-to-noise ratio. The images were analyzed with
the LSM Image Browser (Zeiss).
Supporting Information
Figure S1 Specificity of p50 and p65 binding in TransAM
assays. MA104 cells were infected with A5-16, NCDV, or OSU as
described in the text. Lysates were prepared six hours post
infection and subjected to the (A) p50 or (B) p65 binding assay.
Competitor oligonucleotides are wildtype (w) or mutant (m).
Found at: doi:10.1371/journal.ppat.1000280.s001 (3.00 MB TIF)
Figure S2 Immunoblot analysis of lysates used in luciferase
reporter assays. Cell lysates used in the NFkB and IFNb reporter
luciferase assays (Figure 2B and Figure 1C, respectively) were
analyzed by immunoblot with anti-myc antibody to detect myc-
tagged NSP1. The asterisk indicates a protein that cross-reacts
with the myc antibody. The blots were probed for GAPDH as a
loading control.
Found at: doi:10.1371/journal.ppat.1000280.s002 (0.37 MB TIF)
Figure S3 p65 co-localizes with VP6 and NSP2 in viroplasms.
(A) The cellular localization of p65, VP6, and NSP2 in MA104
cells infected with three pfu/cell of the indicated virus strain was
determined by confocal microscopy (636, NA 1.40) at six hpi. The
zoom function was used to allow for analysis of individual cells. (B)
Interactions between p65 and rotavirus proteins were determined
by co-immunoprecipitation. Rotavirus proteins were radiolabeled
for six hours in MA104 cells infected with ten pfu/cell of the
indicated virus strain (details in Materials and Methods). Cell
lysates were prepared and 10% of each sample was set aside as
input control. The remaining lysate was divided equally for
immunoprecipitation with anti-p65 antibody. Input controls and
immunoprecipitated samples were separated by SDS-PAGE, and
radiolabeled proteins were detected by autoradiography.
Found at: doi:10.1371/journal.ppat.1000280.s003 (2.16 MB TIF)
Figure S4 IkBa degradation is proteasome dependent. MA104
cells were infected with A5-16 in the absence or presence of
10 mM MG132. Immunoblots were probed with anti-IkBa and
anti-GAPDH.
Found at: doi:10.1371/journal.ppat.1000280.s004 (3.00 MB TIF)
Figure S5 b-catenin is stabilized in OSU infected cells. Cell
lysates were collected ten hpi from 293 cells infected with three
pfu/cell of the indicated virus strain. The abundance of b-catenin
was determined by immunoblot and densitometry normalized to
GAPDH. The level of b-catenin in OSU infected cells was ,2–4
fold higher than in mock infected or A5-16 infected cells.
Found at: doi:10.1371/journal.ppat.1000280.s005 (0.72 MB TIF)
Protocol S1 Supplemental methods
Found at: doi:10.1371/journal.ppat.1000280.s006 (0.04 MB
DOC)
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